Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
L&W rise is, indeed, good to see.
BWMG!!!
I was referring to overall revenue and percentage gained YOY. Overall revenue is more in line with what we're actually paying for when we buy stock, not just one product. I suspect Nomad will pick up big in Qtr 3. It wasn't available in Qtr 2. It's always good to see more, but we are looking at the share price of .05, not $1.00 or more.
BWMG!!!
Moving up! Big bidder at .072!
GNPG!!!
This is huge increase when you take out the BluVent project from last year:
(in thousands) Q2-21 Q2-20 Less: Blu3Vent Project Q2-20 (net of Vent project) % Change
Total Net Revenues $ 1,712.50 $ 1,320.50 $ (457.80 ) $ 862.70 98.55 %
98.5%!!!
BWMG!!!!
Brownie's Marine Group Announces 29.7% Increase in Revenues for Q2-2021 vs. Q2-2020
9:00 am ET August 16, 2021 (Globe Newswire) Print
Brownie's Marine Group, Inc. (OTCQB: BWMG), a leading developer, manufacturer and distributor of tankless dive equipment and high-pressure air and industrial compressors in the marine industry, today announced results for the fiscal second quarter and six months ending June 30, 2021.
Chris Constable, CEO of Brownie's Marine Group, Inc. stated, "Brownie's Marine Group continues to grow our core platform businesses every quarter. We are working towards consistent profitability at the adjusted net income level and to the net income level over the next 4 quarters. Second quarter total net revenue increased 29.7% YoY and 36.2% for the six months as it compares to the same period in the prior year. I am very proud of the effort our team has put forth thus far in 2021 and we remain excited about our growth prospects for the second half of this year, especially with the launch of our new product, Nomad, by BLU3."
2 Fiscal Quarter Highlights
Select Financial Metrics: Fiscal 2 Quarter Ended June 30th, 2021, Comparisons
(in thousands) Q2-21 Q2-20 Less: Blu3Vent Project Q2-20 (net of Vent project) % Change
Total Net Revenues $ 1,712.50 $ 1,320.50 $ (457.80 ) $ 862.70 98.55 %
Legacy SSA Products - Brownies Third Lung $ 977.00 $ 626.40 - $ 626.40 55.97 %
High Pressure Gas Systems - LW Americas $ 207.60 $ 75.20 - $ 75.20 176.06 %
Ultra-Portable Tankless Dive Systems - BLU3 $ 528.40 $ 618.90 $ (457.80 ) $ 161.10 228.00 %
Operating Income (loss) $ (257.50 ) $ (407.70 ) $ (101.70 ) $ (509.40 ) 56.96 %
Net Income (loss) $ (89.80 ) $ (414.00 ) $ (101.70 ) $ (515.70 ) 84.50 %
Adjusted Net Income (loss) $ 167.57 $ 260.90 $ (346.70 ) $ (85.80 ) 284.99 %
NM = not measurable/meaningful
Chris Constable, CEO of Brownie's Marine Group, added, "We remain committed to the strategic mindset towards acquisitions and believe our initiations on this front will come to life soon. Both myself and our Chairman, Robert Carmichael, have several innovative companies in the pipeline that we believe could be a strategic fit for us going forward. We hope to have news to communicate with our shareholders very soon on this matter."
Robert M. Carmichael, President and Chairman of the Board added, "In addition to our overall strong operating performance, we are also thrilled with the initial pre-sale campaign results of the Nomad, by BLU3. The Nomad is our next-generation portable, battery powered dive system that will take divers down to 30 ft., for 45-60 minutes on one charge. The Nomad will change the industry landscape for those who want to explore the next atmosphere. Blake and his team are prepared to meet their third quarter, 2021 launch deadline, and through the pre-sale to both consumers and dealers have pre-booked the initial production runs through October. Nomad has been designed to ease the manufacturing process and will allow BLU3 to scale production to meet the demand of an industry that needs a game changing product like Nomad."
Non-GAAP Financial Measures
This press release includes certain financial measures that exclude the impact of certain items and therefore have not been calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). We report adjusted net income (loss) to measure our overall results because we believe it better reflects our net results by excluding the impact of non-cash equity-based compensation. We believe the presentation of adjusted net income (loss) enhances our investors' overall understanding of the financial performance of our business.
We believe that investors should have access to the same set of tools that we use in analyzing our results. This non-GAAP measure should be considered in addition to results prepared in accordance with GAAP but should not be considered a substitute for or superior to GAAP results.
The following is an unaudited reconciliation of adjusted net income (loss) to net income (loss) for the periods presented:
Three Months Ended June 30,
2021 2020
Net income (loss) $ (89,805 ) $ (414,042 )
plus:
Stock issued for services - $ 222,500
Stock-based compensation incentive bonus shares issued to CEO and employees - $ 233,968
Stock-based compensation - options $ 257,370 $ 218,505
Adjusted net income (loss) $ 167,565 $ 260,931
About Brownie's Marine Group
Brownie's Marine Group, Inc., is the parent company to a family of innovative brands with a unique concentration in the industrial, and recreational diving industry. The Company, together with its subsidiaries, designs, tests, manufactures, and distributes recreational hookah diving, yacht-based scuba air compressors and nitrox generation systems, and scuba and water safety products in the United States and internationally. The Company has three subsidiaries: Trebor Industries, Inc., founded in 1981, dba as "Brownie's Third Lung"; BLU3, Inc.; and Brownie's High-Pressure Services, Inc., dba LW Americas. The Company is headquartered in Pompano Beach, Florida.
For more information, visit: www.BrowniesMarineGroup.com.
Safe Harbor Statement
This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected. Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors. Stockholders and potential investors should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements in this report are reasonable, we cannot assure stockholders and potential investors that these plans, intentions or expectations will be achieved. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission (the "SEC") on March 31, 2021, and our other periodic and quarterly filings with the SEC.
Source: Brownie's Marine Group, Inc.
Contact Information: (954)-462-5570
investors@browniesmarinegroup.com
Investor Relations: Hayden IR
Contact: Brett Maas (646) 536-7331
brett@haydenir.com
From report:
NOTE 6: SUBSEQUENT EVENTS
On August 11, 2021, the Company announced the roll-out of its proprietary cutting-edge grinder jars with
honey dipped hemp rolling papers. The Company acquired 10,000 jars from a manufacturer and purchased
200lbs of exotic flower from a premier cultivator seeking to merge into the Company and partnered with a
distributor as it enters distribution of this product. The Company also entered into discussions with the
cultivator to implement growth of its patented seed library as it expands its distribution capabilities.
BWMG!!!!
Like we've said before and as evidenced by this afternoon's move, it doesn't take much volume for BWMG to move. Good set up for next week. 10Q should be out Monday, IMO.
BWMG!!!!!
Amazing! And the best is yet to come, IMO.
BWMG!!!!
10Q should be out by, at least, Monday. Investors want in, and/or add shares. JMO.
BWMG!!!
Yes, loading.
DMAN!!
Next week should be good, leading into the 10Q.
BWMG!!!
Very good point!
BWMG!!
Nice!
BWMG!!!!
That could be true about new high. So far as I know, I like the acquisition, too.
BWMG!!!
I hope they dump some more. I missed that buy opportunity, but bidding now at .055.
GNPG!!!
10Q should be out in the next week or two.
Should be a good one, IMO.
BMWG!!!
I haven't thought much about that, but now that you mentioned it, I believe you have a good point.
MVNT!!!
It's due by the 15th generally, but the 15th is on Sunday so I imagine it will be out on the 13th or the 16th. I agree that it should be a good one.
BWMG!!
SNWV
SANUWAVE Health, Inc.
Common Stock
0.15
0.005
3.45%
0.1434 / 0.17 (1 x 1)
Real-Time Best Bid & Ask: 08:08am 07/29/2021
Delayed (15 Min) Trade Data: 12:00am 07/28/2021
Overview
Quote
Company Profile
Security Details
News
Financials
Disclosure
Research
OTC DISCLOSURE & NEWS SERVICE
SANUWAVE Announces Collaboration with NASA for the Mitigation of Bacterial Biofilms Formed in the Water Processor Assembly used on International Space Station (ISS) and for Future Moon Base and Mars Colony
Press Release | 07/29/2021
SUWANEE, GA, July 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), announces collaboration with National Aeronautics and Space Administration (NASA). One of the most important objectives of this decade for National Aeronautics and Space Administration (NASA) is the restart of missions to the Moon to establish a Lunar Base. This is just the first step for further exploration of other celestial bodies and resources, with the focus on Mars, where the First Human Mars Colony will be constructed in the following decades. The initial training and observation of the influence of extraterrestrial non-gravitational or low gravitational environment on the human body for long periods of time was done onboard of the International Space Station (ISS), where a plethora of cosmonauts from all over the World spent significant time for the last three decades.
The closed loop Water Recovery System (WRS) is essential for the ISS and any Lunar Base or Mars Colony, to provide sufficient water supply for their human inhabitants. Many different technologies have been proposed as solutions to provide nearly total water recovery for long duration space craft missions. However, one of the lessons gathered from the ISS has been biofilm-related issues observed in the WRS and its main component called the Water Processor Assembly (WPA) that produces potable water from a combination of humidity condensate and urine distillate. The ISS experience has shown that the WPA is a hazard to the WRS and has an increased risk for bacterial biofilm formation that ultimately produce WRS failures. This issue is magnified for future NASA manned missions due to the need to place the vehicle’s life support system in a dormant state during non-crew operations (e.g. when the vehicle is in Mars orbit during the surface mission).
SANUWAVE is proud to announce that it was selected as one of the companies that can help with the mitigation of the bacterial biofilms formed inside the WRS. SANUWAVE’s proprietary shockwave technology, which is a highly mechanical energy, will be used to test the detachment, destruction, and ultimately prevention of biofilms formation. Our Company has proven in numerous studies performed at the Center for Biofilm Engineering (CBE) at Montana State University, which is the US main research center for bacterial biofilms, that shockwave technology is capable of the elimination of various Gram-positive and Gram-negative bacterial biofilms.
Our approach toward mitigation of the bacterial biofilms formed inside the WRS, was recently presented at the International Conference on Environmental Systems (ICES), July 12-15, 2021, as part of the published paper titled “Biofilm Management in a Microgravity Water Recovery System.” Dr. Iulian Cioanta, SANUWAVE’s Chief Science and Technology Officer, presented in this paper the design of the experimental approach to test the use of shockwaves for the bellows tank, where the biofilms form usually in the WRS. Based on the existing experimental results, it is believed that the short periodic exposure to only shockwaves or in combination with any other anti-bacterial and/or anti-biofilm technologies, will prevent the biofilm formation, remove patchy biofilms, and reduce the overall free bacteria implementing population in the WRS aboard the ISS.
The experimental design presented in the paper at the ICES 2021 conference will be used in a grant awarded by NASA to systematically assess the shockwave technology influence on the biofilms formed in the water tank of the WPA from the WRS. This research work will be done at the SANUWAVE’s research laboratory and also at CBE, which is one of the main partners for us and also the leading facility that is performing the biofilm work for NASA.
SANUWAVE has patented the use of its proprietary shockwave technology in non-medical fields, such as energy (improved/enhanced oil recovery), water processing (particulate separation), food (bacterial reduction), and biofilm removal (underwater structures cleaning). Patent applications are filed on pipes sludge and scale removal, freezing desalination, membranes cleaning, sludge dewatering, and air/fluid interface materials cleaning. The Company has performed successful confirmatory testing on water cleaning, using an in-house small-scale prototype, and on both medical and non-medical biofilm removal at Center for Biofilm Engineering from Montana State University (MSU).
Dr. Iulian Cioanta commented, “The use of the shockwaves system proposed by SANUWAVE should be suitable for both dormant (no crew on board) and non-dormant periods, as well as being operated for short time periods at set time intervals, as will be determined from the feasibility testing that will be performed as part of the NASA grant. The shockwaves system design was done to easily integrate with the existing ISS WRS hardware. This includes avoiding air entrapment, adding only minimum weight for additional components, easy access to the main components for a rapid exchange in case of failure, and reduce crew involvement in system maintenance or recovery from dormant periods. The shockwaves system has completely non-movable parts, which increase longevity that is important for extraterrestrial structures.”
Kevin Richardson II, the CEO of SANUWAVE, added, “Clean water is crucial for NASA human inhabited structures, and this is why it needs to be recycled. As we know water weight is super high, which prohibits the hauling of it on periodic rocket launches from Earth. This is why the WRS is crucial to the future success of NASA missions to Moon and Mars. The use of shockwaves is simple and efficient and can be combined with other technologies to produce increased efficiency in the elimination and prevention of bacterial biofilms formed inside such a closed-loop system. We are proud to be selected by NASA to be one of their partners and we are looking forward to delivering successful solutions. This work will be used for future development of commercial application for water mitigation, cleaning and disinfection.”
About SANUWAVE Health, Inc.
SANUWAVE Health (OTCQB:SNWV) is focused on the research, development, and commercialization of its patented, Energy First non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body's normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, plastic/cosmetic and cardiac/endovascular conditions. For more information, please visit www.SANUWAVE.com.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company’s product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
SANUWAVE Health, Inc.
Kevin Richardson II
Chairman and Chief Executive Officer
978-922-2447
investorrelations@SANUWAVE.com
Primary Logo
SNWV!
SNWV
SANUWAVE Health, Inc.
Common Stock
0.15
0.005
3.45%
0.1434 / 0.17 (1 x 1)
Real-Time Best Bid & Ask: 08:08am 07/29/2021
OTC DISCLOSURE & NEWS SERVICE
SANUWAVE Announces Collaboration with NASA for the Mitigation of Bacterial Biofilms Formed in the Water Processor Assembly used on International Space Station (ISS) and for Future Moon Base and Mars Colony
Press Release | 07/29/2021
SUWANEE, GA, July 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), announces collaboration with National Aeronautics and Space Administration (NASA). One of the most important objectives of this decade for National Aeronautics and Space Administration (NASA) is the restart of missions to the Moon to establish a Lunar Base. This is just the first step for further exploration of other celestial bodies and resources, with the focus on Mars, where the First Human Mars Colony will be constructed in the following decades. The initial training and observation of the influence of extraterrestrial non-gravitational or low gravitational environment on the human body for long periods of time was done onboard of the International Space Station (ISS), where a plethora of cosmonauts from all over the World spent significant time for the last three decades.
The closed loop Water Recovery System (WRS) is essential for the ISS and any Lunar Base or Mars Colony, to provide sufficient water supply for their human inhabitants. Many different technologies have been proposed as solutions to provide nearly total water recovery for long duration space craft missions. However, one of the lessons gathered from the ISS has been biofilm-related issues observed in the WRS and its main component called the Water Processor Assembly (WPA) that produces potable water from a combination of humidity condensate and urine distillate. The ISS experience has shown that the WPA is a hazard to the WRS and has an increased risk for bacterial biofilm formation that ultimately produce WRS failures. This issue is magnified for future NASA manned missions due to the need to place the vehicle’s life support system in a dormant state during non-crew operations (e.g. when the vehicle is in Mars orbit during the surface mission).
SANUWAVE is proud to announce that it was selected as one of the companies that can help with the mitigation of the bacterial biofilms formed inside the WRS. SANUWAVE’s proprietary shockwave technology, which is a highly mechanical energy, will be used to test the detachment, destruction, and ultimately prevention of biofilms formation. Our Company has proven in numerous studies performed at the Center for Biofilm Engineering (CBE) at Montana State University, which is the US main research center for bacterial biofilms, that shockwave technology is capable of the elimination of various Gram-positive and Gram-negative bacterial biofilms.
Our approach toward mitigation of the bacterial biofilms formed inside the WRS, was recently presented at the International Conference on Environmental Systems (ICES), July 12-15, 2021, as part of the published paper titled “Biofilm Management in a Microgravity Water Recovery System.” Dr. Iulian Cioanta, SANUWAVE’s Chief Science and Technology Officer, presented in this paper the design of the experimental approach to test the use of shockwaves for the bellows tank, where the biofilms form usually in the WRS. Based on the existing experimental results, it is believed that the short periodic exposure to only shockwaves or in combination with any other anti-bacterial and/or anti-biofilm technologies, will prevent the biofilm formation, remove patchy biofilms, and reduce the overall free bacteria implementing population in the WRS aboard the ISS.
The experimental design presented in the paper at the ICES 2021 conference will be used in a grant awarded by NASA to systematically assess the shockwave technology influence on the biofilms formed in the water tank of the WPA from the WRS. This research work will be done at the SANUWAVE’s research laboratory and also at CBE, which is one of the main partners for us and also the leading facility that is performing the biofilm work for NASA.
SANUWAVE has patented the use of its proprietary shockwave technology in non-medical fields, such as energy (improved/enhanced oil recovery), water processing (particulate separation), food (bacterial reduction), and biofilm removal (underwater structures cleaning). Patent applications are filed on pipes sludge and scale removal, freezing desalination, membranes cleaning, sludge dewatering, and air/fluid interface materials cleaning. The Company has performed successful confirmatory testing on water cleaning, using an in-house small-scale prototype, and on both medical and non-medical biofilm removal at Center for Biofilm Engineering from Montana State University (MSU).
Dr. Iulian Cioanta commented, “The use of the shockwaves system proposed by SANUWAVE should be suitable for both dormant (no crew on board) and non-dormant periods, as well as being operated for short time periods at set time intervals, as will be determined from the feasibility testing that will be performed as part of the NASA grant. The shockwaves system design was done to easily integrate with the existing ISS WRS hardware. This includes avoiding air entrapment, adding only minimum weight for additional components, easy access to the main components for a rapid exchange in case of failure, and reduce crew involvement in system maintenance or recovery from dormant periods. The shockwaves system has completely non-movable parts, which increase longevity that is important for extraterrestrial structures.”
Kevin Richardson II, the CEO of SANUWAVE, added, “Clean water is crucial for NASA human inhabited structures, and this is why it needs to be recycled. As we know water weight is super high, which prohibits the hauling of it on periodic rocket launches from Earth. This is why the WRS is crucial to the future success of NASA missions to Moon and Mars. The use of shockwaves is simple and efficient and can be combined with other technologies to produce increased efficiency in the elimination and prevention of bacterial biofilms formed inside such a closed-loop system. We are proud to be selected by NASA to be one of their partners and we are looking forward to delivering successful solutions. This work will be used for future development of commercial application for water mitigation, cleaning and disinfection.”
About SANUWAVE Health, Inc.
SANUWAVE Health (OTCQB:SNWV) is focused on the research, development, and commercialization of its patented, Energy First non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body's normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, plastic/cosmetic and cardiac/endovascular conditions. For more information, please visit www.SANUWAVE.com.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company’s product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
SANUWAVE Health, Inc.
Kevin Richardson II
Chairman and Chief Executive Officer
978-922-2447
investorrelations@SANUWAVE.com
Primary Logo
Wow! Wonder how much revenue we're talking about here?
SNWV!!!
Good one!
Fantastic news!
GNPG!!!
I agree. Bought more today.
DMAN!!
Jumped in today. Thanks.
That sounds plausible.
GNPG!!!
Looking good!
DMAN!!!
Agreed!
DMAN!!!!
Exactly!
Pink sheet, not grey. Filings soon, IMO.
GNPG!!
My thoughts, too. Hanging on for big bucks when they get their filings up to date. Too much going on for them not to get current, IMO.
GNPG!!!
Nice tweet! Let's roll!
DMAN!!!
Buying the dip!
DMAN!!!
That's correct!
DMAN!!!
Exactly! Agreed! Plus I got some cheapies today.
DMAN!!
Added a few more today.
SNWV!
Nice! Congrats!
DMAN!!
IMO, MMs influenced it down to pick up cheap shares ahead of potential news.
DMAN!!!
Seems they gave up on shorting and are now bidding higher than they were selling.
DMAN!!
Seems that the last 4 million, or so, shares have gone at the ask.
DMAN!!!